Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Abametapir 0.74% for Head Lice Infestation
NCT02097485Phase 2Completed
- Sponsor
- Dr. Reddy's Laboratories
- Start
- May 2014
- Primary completion
- Sep 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of abametapir in pediculosis capitis, sponsored by Dr. Reddy's Laboratories. Started May 2014; status: completed.
02
Drugs
abametapir
03
Conditions
pediculosis capitis
Beyond the preview
Go deeper on NCT02097485.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02097485.